Tilray Goes Global With Novartis Cannabis Sales Partnership

Tilray Inc. (Tilray) recently announced it has signed a partnership with Novartis AG (Novartis) subsidiary Sandoz to develop and globally distribute medical cannabis. The move is possible thanks to Tilray building upon its existing alliance with Sandoz Canada Inc., one of the fastest-growing pharmaceutical companies in the Canadian market.

Under the partnership, the organizations plan to commercialize Tilray’s non-smokable medical cannabis products, as well as co-brand some of its products, develop new products, and help educate clinical professionals about cannabis. Tilray leadership cited Sandoz’s focus on consumers, reliable supply chain, well-established sales force, and . . .